Clinical Trial Update: MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma [NA]

View source ↗

Summary

The clinical trial evaluating MoleMapper, Visiomed, and confocal microscopy for melanoma screening has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanocytic Nevus
• Skin Cancer

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Cutaneous Melanoma, Melanocytic Nevus | NA | Status: TERMINATED